Sandie Worley is a Neurology physician affiliated with NewYork–Presbyterian Hospital. OpenAlex indexes 6 publications with 358 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
550 1st Ave
New York, NY 10016
Telephone
212-263-7300Provider last certified this registry record 23 May 2023.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20254 payments
- Boston Scientific CorporationProgram year20252 payments
- InSightec,IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
90.8%Aromatic Amino Acid Decarboxylation Inhibitor49.4%Carbidopa-Levodopa69%Carbidopa-Levodopa Er26%Rytary5%Part D<11 patientsGabapentinoids6.2%Gabapentin100%Part D≥24 patients+ 11 more classes in this area
Cardiovascular
5.4%Beta blocker3.6%Propranolol Hcl Er53%Propranolol Hcl47%Part D<11 patientsalpha-Adrenergic Agonist1.7%Midodrine Hcl100%Part D<11 patientsMusculoskeletal
3.9%gamma-Aminobutyric Acid-ergic Agonist2.5%Baclofen100%Part D<11 patientsMuscle Relaxant1.4%Cyclobenzaprine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants
Journal of Neonatal-Perinatal Medicine
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Lawrence Honig, MD, PhD
NewYork–Presbyterian Hospital
Nasser Altorki, MD
NewYork–Presbyterian Hospital
Michael Niederman, MD
NewYork–Presbyterian Hospital
Shunichi Homma, MD
NewYork–Presbyterian Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”